Stock Markets Analysis & Opinion

Earnings estimates for American Electric Power Company, Inc. (NYSE:AEP) have been revised upward in the past 60 days, reflecting analysts’ optimism on the stock. The Zacks Consensus Estimate...

Recently, Swiss bank UBS Group AG (NYSE:UBS) increased its litigation provisions by about $382 million. This follows the penalty of EUR 4.5 billion ($5.1 billion), slapped on the bank last month, by...

Nucor Corporation (NYSE:NUE) has issued guidance for first-quarter 2019 (ending Mar 30).The steel giant expects earnings per share (EPS) in the band of $1.45-$1.50 for the first quarter. This...

For investors seeking momentum, Invesco Global Water ETF (AX:PIO) is a reasonable bet. The fund just hit a 52-week high, up roughly 22% from its 52-week low price of $22.13/share.Are more gains in...

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) announced that it has dosed the first patient in a phase IIa study — TELE-ABC — evaluating its sole marketed drug, Xermelo (telotristat...

Chevron (NYSE:CVX), $CVX, started moving lower in the middle of 2014 as seen on the weekly chart below. The price bottomed out about a year later. Since then it has trended higher with a couple of...

Monday March 18: Five things the markets are talking aboutGlobal equities start Monday on the front foot in a week that is packed with geopolitical (Brexit, E.U summit – Mar 21/22), economic...

Northern Trusts is one of the major asset management companies, providing a variety of investment solutions and strategies to individuals and institutions. The company manages assets worth more than...

On the lookout for a Global - Equity fund? Starting with MSIF Global Opportunity Portfolio A (MGGPX) should not be a possibility at this time. MGGPX holds a Zacks Mutual Fund Rank of 4 (Sell), which...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) announced that the European Commission (EC) has approved a label expansion of its PCSK9 inhibitor, Praluent.The drug’s label has been expanded to...

Share price of Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) increased 25.4% year to date compared with the industry’s growth of 15.9%. Alnylam is a development-stage biopharmaceutical company...

Bristol-Myers Squibb Company (NYSE:BMY) along with partner Pfizer Inc. (NYSE:PFE) announced results from the phase IV -AUGUSTUS study evaluating the blood thinner drug, Eliquis (apixaban) versus...

Gilead Sciences (NASDAQ:GILD) (GILD) is aresearch-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company’s...

As of late, it has definitely been a great time to be an investor in Vera Bradley, Inc. (NASDAQ:VRA) . The stock has moved higher by 9.5% in the past month, while it is also above its 20 Day SMA too....